University of California San Francisco
Give to UCSFResearchers have found that people who developed breast, ovary, skin and uterine cancers have significantly higher levels of endocrine-disrupting chemicals in their bodies.
Engineered immune cells. Supercharged scans. Drug implants. Gene manipulators. Blood biopsies. Read how these breakthroughs are transforming cancer care.
Two UCSF scientists – James Gardner, MD, PhD, and Rebeca de Pavia Fróes Rocha, PhD – have received Pew awards for their work in immunology as part of a program that supports promising early-career investigators.
Laws in many states require notifying women if they have dense breasts, a risk factor for breast cancer. But density shouldn’t be the only factor in determining whether supplemental screening is
Oncology specialists from around the globe will gather for the American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest cancer therapies, technologies, research and education.
Taking into account genetic factors that can change PSA levels not associated with cancer, the screening accuracy can be improved.
UCSF scientists have found that brain cancer glioblastoma can cause cognitive decline by affecting neural connections, but the epilepsy drug gabapentin shows promise in blocking this activity, offering hope for new treatments.
Transgender women keep their prostates even after gender-affirming surgery, and the estimated risk of prostate cancer is at about 14 cases per 10,000 people.
Leading cancer researchers from UCSF will present at this year’s annual meeting of the American Association for Cancer Research (AACR) conference, held April 14-19, 2023, in Orlando.
Thermo Fisher Scientific Inc. and UCSF will accelerate advanced cell therapies for difficult to treat conditions like cancer from a new manufacturing facility.
A clinical trial showed that, rather than removing lymph nodes, leaving them intact could help immunotherapy activate tumor-fighting T cells in the lymph nodes.
For the past 30 years, the California Tobacco Control Program has helped Californians save $816 billion in health care costs.